Metropolis Healthcare Ltd 542650
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 82.70
- Price/Sales
- 8.93
- Dividend Yield (Trailing)
- 0.18%
- Dividend Yield (Forward)
- 0.18%
- Total Yield
- 0.19%
Company Profile
Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 4,741
- Website
- https://www.metropolisindia.com
Comparables
Valuation
|
Metric
|
542650
|
301060
|
543328
|
|---|---|---|---|
Price/Earnings (Normalized) | 82.70 | 29.68 | 46.11 |
Price/Book Value | 10.17 | 2.15 | 3.36 |
Price/Sales | 8.93 | 2.24 | 4.25 |
Price/Cash Flow | 47.02 | 48.96 | 25.35 |
Price/Earnings
542650
301060
543328
Financial Strength
|
Metric
|
542650
|
301060
|
543328
|
|---|---|---|---|
Quick Ratio | 1.02 | 2.66 | 1.32 |
Current Ratio | 1.28 | 3.27 | 1.50 |
Interest Coverage | 9.64 | −9.75 | 4.36 |
Quick Ratio
542650
301060
543328
Profitability
|
Metric
|
542650
|
301060
|
543328
|
|---|---|---|---|
Return on Assets (Normalized) | — | −4.28% | — |
Return on Equity (Normalized) | — | −7.03% | — |
Return on Invested Capital (Normalized) | — | −5.26% | — |
Return on Assets
542650
301060
543328
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Drfhxjkzs | Gzm | $234.7 Bil | |||
| Danaher Corp
DHR
| Dwgpybdpc | Ywclky | $198.9 Bil | |||
| IQVIA Holdings Inc
IQV
| Xtxnbkknh | Fxhcqf | $42.8 Bil | |||
| Agilent Technologies Inc
A
| Txtbypwlqv | Ywz | $42.5 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Dylyssrj | Ymjp | $42.1 Bil | |||
| Mettler-Toledo International Inc
MTD
| Cwctvvhvb | Bvvrl | $31.4 Bil | |||
| Icon PLC
ICLR
| Mtxzsbkqk | Tgpnwvv | $23.7 Bil | |||
| Waters Corp
WAT
| Fbwprnbql | Gtxs | $21.2 Bil | |||
| Illumina Inc
ILMN
| Gqznlczbx | Yrklkk | $20.7 Bil | |||
| Labcorp Holdings Inc
LH
| Mhknnyfnj | Mgncw | $18.6 Bil |
United States